Entamoeba histolytica
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A protozoan parasite acquired from contaminated food and water, mainly in travelers and immigrants from endemic areas.
Infections
Amebic colitis (dysentery) and amebic liver abscess.
Signs and symptoms
Bloody diarrhea, abdominal pain; fever and right upper quadrant pain with liver abscess.
Antibiotic and antimicrobial resistance
Resistance to metronidazole or tinidazole is not a recognized clinical problem. A second, luminal agent is added to clear cysts from the gut.
Treatment considerations
Metronidazole or tinidazole followed by a luminal agent (paromomycin).

Sources
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.